Outcomes in COVID-19 Patients with Pneumonia Treated with High-Flow Oxygen Therapy and Baricitinib—Retrospective Single-Center Study

Background. The aim of the study was to assess the effect of baricitinib on 28-day all-cause mortality and the progression of respiratory failure in patients needing transfer to the intensive care unit (ICU) with COVID-19 pneumonia treated with high-flow oxygen therapy. Methods. This retrospective s...

Descripción completa

Detalles Bibliográficos
Autores principales: Obradović, Dušanka, Popović, Milica, Banjac, Maja, Bulajić, Jelena, Đurović, Vladimir, Urošević, Ivana, Milovančev, Aleksandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053916/
https://www.ncbi.nlm.nih.gov/pubmed/36983910
http://dx.doi.org/10.3390/life13030755

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053916/
https://www.ncbi.nlm.nih.gov/pubmed/36983910
http://dx.doi.org/10.3390/life13030755

Ejemplares similares